|
Contents
|
|
|
|
|
|
|
Astrocytoma |
|
|
|
Bela Bodey, Vivian Bodey, Stuart E. Siegel,
Hans E. Kaiser
Mage-1, a cancer-testis antigen, and p53 expression in
childhood astrocytomas as an indicator of tumor progression
Proceedings
of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 158
|
|
|
Fulci G, Ishii N, Maurici D, Gernert KM, Hainaut P,
Kaur B, Van Meir EG.
Initiation of human astrocytoma by clonal
evolution of cells with progressive
loss of p53 functions in a patient with a 283H TP53 germ-line mutation:
evidence for a precursor lesion
Cancer Res. 2002 May 15;62(10):2897-905
.JPG)
Abstract |
.png)
Full Text | .png)
Reprint
|
|
Giulia
Fulci, Nobuaki Ishii, Daniela Maurici, Kim M. Gernert, Pierre Hainaut
and Erwin G. Van Meir
Genetic
evidence for a precursor lesion to astrocytoma WHO grade II in a patient
with a germline TP53 mutation and astrocytoma progression
Proc. Int. Symp. “New
Treatments for Brain Tumors: Gene Therapy and Neural Stem Cells”.
Parma, Italy, October 17-20, 2001. Abstract
No. O-3
|
|
|
Groenendijk
FH, Taal W, Dubbink HJ, Haarloo CR, Kouwenhoven MC, van den Bent MJ, Kros JM,
Dinjens WN.
MGMT promoter hypermethylation is a frequent, early, and consistent event in
astrocytoma progression, and not correlated with TP53 mutation
J Neurooncol. 2010 Jul 1;. [Epub ahead of print]
Abstract |
Full Text |
Reprint
|
|
Lee
A, Maldonado M, Baybis M, Walsh CA, Scheithauer B, Yeung R, Parent J,
Weiner HL, Crino PB
Markers
of cellular proliferation are expressed in cortical tubers
Ann Neurol. 2003 May;53(5):668-73
|
|
|
Payne CA, Maleki S, Messina M, O'Sullivan MG,
Stone G, Hall NR, Parkinson JF, Wheeler HR, Cook RJ, Biggs MT, Little NS,
Teo C, Robinson BG, McDonald KL.
Loss of prostaglandin D2 synthase: a key molecular event in the
transition of a low-grade astrocytoma to an anaplastic astrocytoma
Mol Cancer Ther. 2008 Oct 1;7(10):3420-8
Abstract
|
|
|
Ranjan M, Santosh V, Tandon A, Anandh B, Sampath S, Devi BI, Chandramouli
BA.
Factors predicting progression of low-grade diffusely infiltrating
astrocytoma.
Neurol India 2011;59:248-253. Epub 2011 Apr 7.
Abstract |
Full
text
|
|
|
Basic
Science |
|
|
|
|
Janine T. Erler, Kevin L. Bennewith,
Monica Nicolau, Nadja Dornhöfer, Christina Kong, Quynh-Thu Le, Jen-Tsan
Ashley Chi, Stefanie S. Jeffrey and Amato J. Giaccia
Lysyl
oxidase is essential for hypoxia-induced metastasis
Nature, 440, 1222-1226 (27 April 2006); doi:10.1038/nature04695
Abstract
| .gif)
News
|
|
|
Brain
Tumors |
|
|
|
|
Charles
N, Holland EC
The perivascular niche microenvironment in brain tumor progression
Cell Cycle. 2010 Aug 17;9(15). [Epub ahead of print]
Abstract
|
|
|
Ganglioglioma |
|
|
|
|
Majores
M, von Lehe M, Fassunke J, Schramm J, Becker AJ, Simon M
Tumor
recurrence and malignant progression of gangliogliomas
Cancer. 2008 Dec
15;113(12):3355-63
Abstract
|
|
|
Glioblastoma |
|
|
|
|
Aoki H, Yokoyama T, Fujiwara K, Tari AM, Sawaya
R, Suki D, Hess KR, Aldape KD, Kondo S, Kumar R, Kondo Y.
Phosphorylated Pak1 Level in the Cytoplasm Correlates with Shorter
Survival Time in Patients with Glioblastoma.
Clin
Cancer Res. 2007 Nov 15;13(22):6603-6609.
Abstract
|
|
Christine
Glanz, Johan Rebetz, Ylva Stewénius, David Gisselsson, Anna Darabi,
Elisabet Englund, Leif G. Salford, Bengt Widegren, Xiaolong Fan
Genetic
identification of glioblastoma maintaining cells in a xenograft model
96th AACR Annual Meeting, Anaheim/Orange County, CA, April
16-20, 2005
Proc Amer Assoc Cancer Res
2005;46:Abstract
No.2045
|
|
|
Nolte
I, Przibylla H, Bostel T, Groden C, Brockmann MA
Tumor-platelet interactions: Glioblastoma growth is accompanied by
increasing platelet counts
Clin Neurol Neurosurg. 2008 Feb 1; [Epub ahead of print]
Abstract
|
|
|
Ohgaki H, Kleihues P
Genetic pathways to primary and secondary glioblastoma
Am J
Pathol. 2007 May;170(5):1445-53
Abstract |
Full Text |
Reprint
|
|
|
Ohgaki H, Dessen P, Jourde B, Horstmann S,
Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka
PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P
Genetic pathways to glioblastoma: a population-based study
Cancer Res. 2004
Oct 1;64(19):6892-9
Abstract |
Full Text |
Reprint
|
|
|
Sato
A, Sakurada K, Kumabe T, Sasajima T, Beppu T, Asano K, Ohkuma H, Ogawa A,
Mizoi K, Tominaga T, Kitanaka C, Kayama T
Association of stem cell marker CD133 expression with dissemination of
glioblastomas
Neurosurg Rev. 2010 Apr;33(2):175-83; Epub 2010 Feb 5.
Abstract
|
|
|
Schwartzbaum
JA, Huang K, Lawler S, Ding B, Yu J, Chiocca EA.
Allergy and inflammatory transcriptome is predominantly negatively
correlated with CD133 expression in glioblastoma
Neuro Oncol. 2010 Apr;12(4):320-7. Epub 2009 Dec 24
Abstract
|
|
|
Suvà ML,
Riggi N, Janiszewska M, Radovanovic I, Provero P, Stehle JC, Baumer K, Le
Bitoux MA, Marino D, Cironi L, Marquez VE, Clément V, Stamenkovic I.
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Cancer Res. 2009 Nov 24;. [Epub ahead of print]
Abstract
|
|
|
Gliomas |
|
|
|
Baltuch
GH, Yong VW
Signal
transduction for proliferation of glioma cells in vitro occurs predominantly
through a protein kinase C-mediated pathway
Brain Res 1996 Feb 26;710(1-2):143-9
|
|
|
Basanta
D, Simon M, Hatzikirou H, Deutsch A
Evolutionary
game theory elucidates the role of glycolysis in glioma progression and
invasion
Cell Prolif.
2008 Dec;41(6):980-7. Published Online: 18 Nov 2008
Abstract |
Full Text |
Reprint |
Comment
|
|
|
Hong TM, Teng LJ, Shun CT, Peng MC, Tsai JC
Induced
interleukin-8 expression in gliomas by tumor-associated macrophages
J Neurooncol.
2009 Jan 21. [Epub ahead of print]
Abstract
|
|
|
Huang Q, Zhang QB, Dong J, Wu YY, Shen YT, Zhao
YD, Zhu YD, Diao Y, Wang AD, Lan Q
Glioma stem cells are more aggressive in recurrent tumors with malignant
progression than in the primary tumor, and both can be maintained long-term
in vitro
BMC Cancer. 2008 Oct 22;8(1):304.
[Epub ahead of print]
Abstract |
Reprint
|
|
Kim MS, Park MJ, Moon EJ, Kim SJ, Lee CH, Yoo H, Shin SH, Song ES, Lee
SH
Hyaluronic Acid Induces Osteopontin via the
Phosphatidylinositol 3-Kinase/Akt Pathway to Enhance the Motility of Human
Glioma Cells
Cancer
Res. 2005 Feb 1;65(3):686-91
|
|
|
Fatima W.
Khwaja,
Jonathan S. Duke-Cohan,
Daniel J. Brat and Erwin
G. Van Meir
Attractin Is Elevated in the
Cerebrospinal Fluid of Patients with Malignant Astrocytoma and Mediates
Glioma Cell Migration
Clin
Cancer Res. 2006 Nov 1;12(21):6331-6
|
|
|
Martin
M
Can
game theory explain invasive tumor metabolism?
J
Natl Cancer Inst. 2009 Feb 18;101(4):220-2. Epub 2009 Feb 10
Abstract |
Commented
|
|
|
Moore LM, Holmes KM, Fuller GN, Zhang W.
Oncogene interactions are required for glioma development and progression as
revealed by a tissue specific transgenic mouse model.
Chin J Cancer. 2011 Mar;30(3):163-72.
Abstract |
Reprint |
.gif) Related articles
|
|
Tom
Nabhani, Ichiro Nakano, Rebecca Erickson, Robert Prins, Harley Kornblum,
Linda M. Liau
Granulin
promotes proliferation and aggregation of differentiating neural progenitors
96th AACR Annual Meeting, Anaheim/Orange County, CA, April
16-20, 2005
Proc Amer Assoc Cancer Res
2005;46:Abstract
No.LB-124
|
|
|
Schiffer
D, Annovazzi L, Caldera V, Mellai M.
On the origin and growth of gliomas
Anticancer Res. 2010 Jun;30(6):1977-98
Abstract
|
|
Villeneuve J, Tremblay P, Vallieres L
Tumor necrosis factor reduces brain tumor growth by
enhancing macrophage recruitment and microcyst formation
Cancer
Res. 2005 May 1;65(9):3928-36. (Abstract+)
|
|
|
Gliomas (Low-Grade) |
|
|
|
|
Idbaih A, Carvalho Silva R, Crinière E, Marie
Y, Carpentier C, Boisselier B, Taillibert S, Rousseau A, Mokhtari K, Ducray
F, Thillet J, Sanson M, Hoang-Xuan K, Delattre JY
Genomic changes in progression of low-grade gliomas
J Neurooncol.
2008 Jul 11. [Epub ahead of print]
Abstract
|
|
|
Stokland
T, Liu JF, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker
DA.
A multivariate analysis of factors determining tumor progression in
childhood low-grade glioma: a population-based cohort study (CCLG CNS9702)
Neuro Oncol. 2010 Sep 22;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Yue
WY, Yu SH, Zhao SG, Chen ZP
Molecular
markers relating to malignant progression in Grade II astrocytoma
J Neurosurg.
2009 Apr;110(4):709-14
Abstract
|
|
|
Gliomatosis
Cerebri
|
|
|
|
|
Jimenez
P, Mollejo M, Marsal C.
[Gliomatosis cerebri: evolution to glioblastoma multiforme.]
Neurologia.
2007 Jul-Aug;22(6):391-4. Spanish.
PMID:
17610168 [PubMed - in process]
|
|
|
Kong DS, Kim MH, Park WY, Suh YL, Lee JI, Park
K, Kim JH, Nam DH
The progression of gliomas is associated with cancer stem cell phenotype
Oncol Rep. 2008 Mar;19(3):639-43
Abstract
|
|
|
Medullobtastoma
|
|
|
|
|
Coco
S, Valdora F, Bonassi S, Scaruffi P, Stigliani S, Oberthuer A, Berthold F,
Andolfo I, Servidei T, Riccardi R, Basso E, Iolascon A, Tonini GP.
Chromosome 9q and 16q Loss Identified by Genome-Wide Pooled-Analysis Are
Associated with Tumor Aggressiveness in Patients with Classic
Medulloblastoma.
OMICS. 2011 Feb 24;. [Epub ahead of print]
Abstract
| Related
articles
|
|
|
Korshunov A, Benner A, Remke M, Lichter P, von
Deimling A, Pfister S
Accumulation of genomic aberrations during clinical progression of
medulloblastoma
Acta
Neuropathol. 2008 Oct;116(4):383-90. Epub 2008 Aug 15
Abstract
|
Full Text
|
Reprint
|
|
|
Meningioma
|
|
|
|
Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain
M
Malignant progression in meningioma: documentation of a
series and analysis of cytogenetic findings
J Neurosurg. 2004 Aug;101(2):210-8
|
|
Bernhard
Braun, Manfred Lange, Reinhard Oeckler,
Margareta M. Mueller
Expression of G-CSF and GM-CSF in Human Meningiomas Correlates with
Increased Tumor Proliferation and Vascularization
Journal of Neuro-Oncology, 68 (2): 131-140, June 2004. (Abstract+)
|
|
|
Ketter R, Rahnenführer J, Henn W, Kim YJ,
Feiden W, Steudel WI, Zang KD, Urbschat S
Correspondence of tumor localization with tumor recurrence and
cytogenetic progression in meningiomas
Neurosurgery. 2008
Jan;62(1):61-9;
discussion 69-70
Abstract
|
|
C. Marosi, M. Hassler, J. A.
Hainfellner, M. Van Trotsenburg, M. Preusser, P. Birner, J. Berger
Microvessel density in progressive meningiomas and
its influence on time to tumour recurrence
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1563
|
|
Surace EI, Lusis E, Haipek CA, Gutmann
DH
Functional significance of S6K overexpression in meningioma
progression
Ann Neurol. 2004 Aug;56(2):295-8
|
|
|
Neuroblastoma
|
|
|
|
Indroneil Mukerji,
Shakti H. Ramkissoon, Kavitha K. R. Reddy and
Pranela Rameshwar
Autocrine proliferation of
neuroblastoma cells is partly mediated through neurokinin receptors:
relevance to bone marrow metastasis
Journal
of Neuro-Oncology, 71(2):
91-98, January 2005. (Abstract+)
|
|
|
Oligodendroglioma
|
|
|
|
|
Campbell BA, Horsman DE, Maguire J, Young S,
Curman D, Ma R, Thiessen B
Chromosomal alterations in oligodendroglial tumours over multiple
surgeries: is tumour progression associated with change in 1p/19q status?
J Neurooncol.
2008 Aug;89(1):37-45.
Epub 2008 May 6
Abstract
|
|
He
J, Mokhtari K, Sanson M, Marie Y, Kujas M, Huguet S, Leuraud P,
Capelle L, Delattre JY, Poirier J, Hoang-Xuan K
Glioblastomas
with an oligodendroglial component: a pathological and molecular study
J
Neuropathol Exp Neurol. 2001
Sep;60(9):863-71
|
|
He
J, Hoang-Xuan K, Marie Y, Leuraud P, Mokhtari K, Kujas M, Delattre JY,
Sanson M
P18
tumor suppressor gene and progression of oligodendrogliomas to anaplasia
Neurology.
2000 Sep 26;55(6):867-9
|
|
Tchougounova
E, Kastemar M, Brasater D, Holland EC, Westermark B, Uhrbom L.
Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
Oncogene. 2007 Apr 16; [Epub
ahead of print]
PMID: 17438529 [PubMed - as supplied by publisher]
|
|
|
Pediatric
Patients
|
|
|
|
|
Nakamura
M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
Molecular pathogenesis of pediatric astrocytic tumors
Neuro Oncol. 2007
Apr;9(2):113-23.
Epub 2007 Feb 27
Abstract |
Full Text |
Reprint
|
|
